[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...

Just over half of U.S. adults (53%) say they’ve gotten neither the flu shot nor the updated COVID-19 vaccine since last ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

The latest generation of COVID-19 vaccines demonstrates remarkable precision in addressing current viral threats. The mRNA vaccines from Pfizer and Moderna specifically target the KP.2 variant ...

Next: Get access to a new market-moving chart every ... company’s COVID-19 vaccines due to reduced market demand. In addition, write-downs by BioNTech’s collaboration partner Pfizer Inc ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

His time at Pfizer has coincided with the spectacular success of its BioNTech-partnered mRNA vaccine for COVID-19 – Comirnaty – and as GSK itself struggled to make headway with its own ...

A healthcare worker fills a syringe with the Pfizer COVID-19 vaccine at Jackson Memorial Hospital, Oct. 5, 2021, in Miami. Lynne Sladky/AP The CDC, however, has previously stated vaccination ...

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, ...

A German court in Duesseldorf ruled that Pfizer and partner BioNTech broke a coronavirus vaccine patent held by Moderna, Reuters reports. -- The court said Pfizer and BioNTech would have to ...